You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 07 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Premedication and Supportive Measures section, added link to T-Cell Engaging Antibody Guideline.

Updated
Aug 2025
Regimen
Published Date: 07 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Premedication and Supportive Measures section, added link to T-Cell Engaging Antibody Guideline.

Updated
Aug 2025
Drug

Published Date: 07 Aug 2025

Revision Summary:
Drug Monograph: Updated Adverse Effects, Dosing, Administration, Warnings and Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline.
Patient Info Sheet EN: Updated patient information sheet
Updated
Aug 2025
Regimen
Published Date: 07 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Funding information, Premedication and Supportive Measures, Dose Modifications, Drug Administration and Special Precautions, and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline

Updated
Aug 2025
Regimen
Published Date: 06 Aug 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated drug regimen section

Updated
Aug 2025
Regimen
Published Date: 22 Jul 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Updated
Jul 2025
Regimen
Published Date: 05 Aug 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Revision Summary:
Patient Info Sheet EN: New patient medication information sheet
Updated
Aug 2025
Regimen
Published Date: 05 Aug 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Revision Summary:
Patient Info Sheet EN: Revised patient regimen information sheet.
Updated
Aug 2025
Regimen
Published Date: 01 Aug 2025
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses and Supplementary Public Funding sections

Updated
Aug 2025
Regimen
Published Date: 01 Aug 2025
Cancer Type:
Genitourinary, 
Prostate
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: Updated Intent, Rationale/Uses, Supplementary Public Funding, Drug Regimen, Cycle Frequency, and Administration sections

Updated
Aug 2025
Drug

Published Date: 01 Aug 2025

Revision Summary:
Drug Monograph: Updated Supplementary Public Funding section
Updated
Aug 2025
Drug

Published Date: 01 Aug 2025

Revision Summary:
Drug Monograph: Updated Supplementary Public Funding section
Updated
Aug 2025

Pages